Neuropsychological and behavioural correlates of CSF biomarkers in dementia
Authors:
- Karen MaertensKMKaren Maertens
- Ellen VloeberghsEVEllen Vloeberghs
- Tony AertsTATony Aerts
- Nore SomersNSNore Somers
- Peter MariënPMPeter Mariën
- Peter P. De DeynPDPeter P. De Deyn
- 1 March 2006
- journal article
- Published by Elsevier in Neurochemistry International
- Vol. 48 (4) , 286-295
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- CSF biomarkers for mild cognitive impairment and early Alzheimer's diseaseClinical Neurology and Neurosurgery, 2005
- CSF markers for pathogenic processes in Alzheimer’s disease: diagnostic implications and use in clinical neurochemistryBrain Research Bulletin, 2003
- Cerebrospinal fluid levels of total-tau, phospho-tau and Aβ42 predicts development of Alzheimer's disease in patients with mild cognitive impairmentActa Neurologica Scandinavica, 2003
- Neuropsychiatric symptoms in the dementiasCurrent Opinion in Neurology, 2002
- Relationships Among Cerebrospinal Fluid Biomarkers in Dementia of the Alzheimer TypeAlzheimer Disease & Associated Disorders, 2002
- Evaluation of CSF-tau and CSF-Aβ42 as Diagnostic Markers for Alzheimer Disease in Clinical PracticeArchives of Neurology, 2001
- Cerebrospinal Fluid β-Amyloid(1-42) in Alzheimer DiseaseArchives of Neurology, 1999
- Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease: a community based follow up studyJournal of Neurology, Neurosurgery & Psychiatry, 1998
- A Description of Agitation in a Nursing HomeJournal of Gerontology, 1989
- Cornell scale for depression in dementiaBiological Psychiatry, 1988